We are a motivated and enthusiastic group of scientists working on rare diseases. The long term goal of our research group is to identify and characterize novel genes that underlie development, function and pathologies of the nervous system. We apply next generation sequencing technology to prioritize potentially causative variants in undiagnosed neurodevelopmental disorders. For functional validation of prioritized variants we undertake a multidisciplinary approach and aim to harness our discoveries for genetic diagnoses and development of efficient and personalized therapeutic strategies.
Aphorism “when you hear hoofbeats behind you, don’t think zebras” is often used to train students of medicine to exclude rare and exotic diagnoses when seeing their patients. For exactly this reason, the zebra became a symbol for rare diseases. There are more than 7000 different known rare disorders, collectively affecting approximately 350 million people worldwide, and 35 million in Europe alone.
Our logo design is a colorful zebra patterned human brain to represent different rare diseases of the nervous system, each unique and rare, as are all rare disease patients.
We are always interested in motivated and enthusiastic scientists to join our team! If you don't see the position you are interested in listed below, please contact us by clicking the button on the right.
Full-time PhD position
We are seeking a curious, independent and hard working individual with interest in neurology, genetics, and intellectual disabilities to join our team. Strong background in molecular and cellular neuroscience is a plus. We recruit through the Ce-M-M- PhD Program, for more information, please click the button on the right.
Oct. 29-30 2021
Turkish Society of Medical Biology and Genetics 17th Congress
Vanja will be presenting our work titled "Using forward and reverse genetics to understand molecular and cellular pathologies in neurodevelopmental disorders" at the biannual meeting of the Turkish Society of Medical Biology and Genetics Congress to take place online. For more information and how to register please check out https://tbgk2021.org/en/page/invitation .
Nov. 11 2021 at 11:00 am
Medical University of Vienna; Centre of Physiology & Pharmacology; Institute of Pharmacology
Vanja will be presenting our work on characterizing novel neurodevelopmental disorders using genetic mouse and fly models as well as human stem cells.
Nov. 08-16 2021
Society for Neuroscience Conference, Chicago, IL, USA
Visit Chris' poster "Fibcd1 is a conserved receptor for CS-4S of the brain's extracellular matrix" and find out more about this exciting project. Virtual: November 8-11, In-Person: November 13-16, Chicago, IL --> date and time information TBA!
News and announcements
7-8 Oct. 2021
At our second annual lab retreat at Prein am der Rax we celebrated our 5th birthday! With a future focused theme, we discussed introducing new cutting-edge technologies into the research, career plans of all the members, as well as inspiring talks from Sejla Sejlic from bit.bio discovery, Joshua Bagley from a:head bio AG and Michael Orthofer from JLP Health. We are grateful to all of our guests, and look forward to another 5 years!
30 Sept. 2021
We congratulate our postdoc Dr. Swaroop Achuta for the poster award he received at the 17th Austrian Neuroscience Association meeting in Salzburg, Austria! We are grateful to the organizers for a fantastic meeting and look forward to seeing everyone next year. Great way to start in-person meetings again!
27 Sept. 2021
Studying genes causing very rare diseases that affect only a few people around the world can teach us about basic biology underlining diseases that affect a large number of us. In our latest paper out today, we describe the function of PRDM12, a transcriptional regulator that is involved in a rare disorder of the peripheral nervous system that causes a complete absence of pain perception, Congenital Insensitivity to Pain. There are only a few 100 people out there with this rare disease. We report that PRDM12 is critical during development but also still active in adults. These data are hopeful, as they imply PRDM12 to be a viable therapeutic target for chronic pain that affects 30% of people sometime in their life world wide. Check out our work and let us know what you think. Link on the right!
27 Sept. 2021
We are excited for the publication of our first case report in Human Genome Variation titled "Expanding the known phenotype of Mullegama-Klein-Martinez syndrome in male patients". First author, Fiona Freyberger, used whole exome sequencing to identify a rare causative mutation in STAG2 gene in a young patient with a complex neurodevelopmental disorder. This is only the 19th case of this disease published so far. Click to the link on the right for more information. We are grateful to our clinical collaborators and especially to the patient and his family.
23 Sept. 2021
We were excited to join our colleagues from the Medical University of Vienna to support Michael Craig Gradwell on his 2,800 km bike ride to raise awareness for the rare disease ALS and to raise financial support for ALS research. Read all about his journey on his facebook page: https://www.facebook.com/Michaelcraiggr
We wish him luck and good health!!
11 Sept. 2021
We are proud to announce our first preprint in bioRxiv! A collaborative effort spearheaded by Chris Fell and Astrid Hagelkruys from the J. Penninger group describing a novel role of the chitin receptor FIBCD1 in neuronal function and pathophysiology of a rare neurodevelopmental disorder. The link to the paper on the right! Check it out and let us know what you think!
14 June 2021
Another really fun lab outing just to celebrate the privilege of getting vaccinated, the beauty of the summer heat, and reopening of public spaces and restaurants in Vienna! We started with Indiana Jones-themed escape room and topped it off with a nice outdoor restaurant that ended in high speed scooter rides through the Vienna center!
14 April 2021
Congratulations to our postdoc Dr. Swaroop Achuta for being one of the finalists for the 3Brain Massimo Grattarola Award for innovative ideas in technological advancement in neuroscience research!
22 March 2021
The Nagy team welcomes its first MD undergraduate student, Haluk Caliskan, who will as part of his thesis project work on whole-exome sequencing and genetics analysis of undiagnosed neurodevelopmental cases. Welcome Haluk!
15-16 March 2021
The first European Syngap1 and Related Neurodevelopmental Disorders Symposium was a smashing success! We heard talks from a combination of renown neuroscientists, top notch clinicians, patient organizations and parents with affected children. We are grateful to our fellow organizers and admins' support, and especially thankful to the patient organization group Leon&Friends for making all of this happen. Special thanks to Chris Fell for his superb IT skills during the conference. Looking forward to next year!
Get to know this wonderful and active patient advocacy organization Leon&Friends by visiting their website by clicking their logo.
18 Feb. 2021
14:00-17:00 Edenhofer/Nagy Gene Editing in Neural Cells Workshop
Workshop is organized to foster collaboration and communication between the two research groups with a common interest in genome editing screens in neurons.
25 Feb. 2021
Nagy lab outing! The weather is finally warming up, Spring is almost here, its time to be outside! There are not many opportunities to spend time together during COVID quarantines, so we are off to a peri-Vienna hike.
March issue of the journal Trends in Molecular Medicine not only includes Chris' Opinion article "Cellular Models and High-Throughput Screening for Genetic Causality of Intellectual Disability" but also highlights Vanja's scientific journey as part of their Stories in Molecular Medicine segment. Our unbiased opinion is that this is definitely the issue to check out!
12. Feb. 2021
There are more than 7000 different rare diseases, most without any treatments. Amazingly, for a metabolic disorder erythropoietic protoporphyria (OMIM# 177000), marked by light sensitivity and extreme pain, there is an EMA approved treatment, Afamelanotide, which has been shown to allow people with this condition to live a nearly normal, pain-free life! Shockingly, in Austria, Afamelanotide is only available to 5 people (?!) Luckily, you can do something about this. Make your voice heard and help people with this rare and difficult condition see the light of day (literally!!) Simply, sign the petition! Its the least you can do for rare disease month.
02 Jan. 2021
PhD Student Christopher Fell's Opinion article titled "Cellular Models and High-Throughput Screening for Genetic Causality of Intellectual Disability" is online at Trends in Molecular Medicine! Congrats Chris!
01 Nov. 2020
New postdoctoral fellow, Dr. Swaroop Achuta joins the lab. Welcome Swaroop!
08 Aug. 2020
PhD Students Sophie Imhof and Dr. Tomislav Kokotovic's forum article titled "PRDM12: New Opportunity in Pain Research" published in Trends in Molecular Medicine! congrats Sophie and Tomislav!
03 Aug. 2020
The Nagy team is awarded the FWF 1000s Ideas Programme grant for their work titled:"Reverse Engineering of Neurodevelopmental Disorders". The grant was co-authored by PhD Student Christopher Fell and will be spearheaded by PhD student Victoria Kartysh.
01 Aug. 2020
New PhD student Victoria Kartysh joins the lab. Welcome Victoria!